检索结果 - M B Agarwal

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    Four-Year Outcomes by Donor Type from the Long-Term Extension of the Belatacept BENEFIT and BENEFIT-EXT Studies

    Four-Year Outcomes by Donor Type from the Long-Term Extension of the Belatacept BENEFIT and BENEFIT-EXT Studies 由 Antoine Dürrbach, José Medina‐Pestana, Thomas Becker, J. Grinyó, P.-O. Lang, Valenzuela García, M B Agarwal, Tao Duan, Samuel C. Florman

    出版 2012
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  2. 2
    Dasatinib or imatinib in newly diagnosed chronic-phase chronic myeloid leukemia: 2-year follow-up from a randomized phase 3 trial (DASISION)

    Dasatinib or imatinib in newly diagnosed chronic-phase chronic myeloid leukemia: 2-year follow-up from a randomized phase 3 trial (DASISION) 由 Hagop M. Kantarjian, Neil P. Shah, Jorge E. Cortés, Michele Baccarani, M B Agarwal, María Soledad Undurraga, Jianxiang Wang, Juan Julio Kassack Ipiña, Dong‐Wook Kim, Michinori Ogura, Carolina Pavlovsky, Christian Junghanß, Jorge Milone, Franck E. Nicolini, Tadeusz Robak, Jan Van Droogenbroeck, Edo Vellenga, M. Brigid Bradley‐Garelik, Chao Zhu, Andreas Hochhaus

    出版 2011
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:

检索工具: